78R-29301-60508 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-30
Registered in v-safe
2020-12-30
Dose 1 — Pfizer-BioNTech
2020-12-30
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2020-12-31
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-20
Dose 2 — Pfizer-BioNTech
2021-01-21
Survey response — days 1–6 daily, dose 2
MedDRA: Pelvic pain, Renal pain, Tachycardia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Tachycardia (130-146), pelvic pain, kidney pain, organ pain,

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-22
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Abdominal pain

Adult check-in
2021-01-27
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-03
Survey response — day 42, dose 2
MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: UTI

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-03
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-21
Survey response — 3 months, dose 2
MedDRA: Condition aggravated, Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: I have had a scalp condition/irritation and increased hair loss/thinning. · Healthcare visit (other): Pending dermatology appointment

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-03
Call 1 — Left Voicemail
2021-07-21
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-22
Survey response — 12 months, dose 2
MedDRA: Autonomic nervous system imbalance, Dizziness, Intracranial pressure increased, Tachycardia, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Tachycardia, dizziness, dysautonomia, intracranial hypertension. · Healthcare visit (other): Rule out a brain tumor

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-01-25
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-30	Pfizer-BioNTech
2	2021-01-20	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-31	priority 2/3
2021-03-03	Unsuccessful
2021-04-21	Unsuccessful
2022-01-22	Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): Tachycardia (130-146), pelvic pain, kidney pain, organ pain,

2021-01-22

Systemic reaction (other): Dizziness

Release 4 — day 42, dose 2

2021-03-03

Symptoms: UTI

Release 7 — 3 months, dose 2

2021-04-21

Symptoms: I have had a scalp condition/irritation and increased hair loss/thinning.

Healthcare visit (other): Pending dermatology appointment

Release 11 — 12 months, dose 2

2022-01-22

Symptoms: Tachycardia, dizziness, dysautonomia, intracranial hypertension.

Healthcare visit (other): Rule out a brain tumor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Autonomic nervous system imbalance	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	Dizziness	·	·	✓
SD	Intracranial pressure increased	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Tachycardia	·	·	✓
SD	Urinary tract infection	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Pelvic pain	✓	✓	✓
SRO	Renal pain	✓	✓	✓
SRO	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release